Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:March 28, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:March 28, 2014Completed
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:April 2, 2020Completed
Condition(s):Normal Tension GlaucomaLast Updated:August 6, 2021Unknown status
Condition(s):Idiopathic Eyelash HypotrichosisLast Updated:February 10, 2015Completed
Condition(s):Healthy VolunteersLast Updated:November 14, 2023Completed
Condition(s):Alopecia; Breast CancerLast Updated:July 31, 2020Withdrawn
Condition(s):Glaucoma, Angle-ClosureLast Updated:December 5, 2007Unknown status
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:June 11, 2020Completed
Condition(s):Glaucoma; Ocular HypertensionLast Updated:November 30, 2010Completed
Condition(s):Vitiligo; RepigmentationLast Updated:August 3, 2011Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.